- Home
- SD vs ZVRA Comparison
SD vs ZVRA Comparison
Compare SD & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SD
- ZVRA
- Stock Information
- Founded
- SD 2006
- ZVRA 2006
- Country
- SD United States
- ZVRA United States
- Employees
- SD N/A
- ZVRA 59
- Industry
- SD Oil & Gas Production
- ZVRA Biotechnology: Pharmaceutical Preparations
- Sector
- SD Energy
- ZVRA Health Care
- Exchange
- SD Nasdaq
- ZVRA Nasdaq
- Market Cap
- SD 380.8M
- ZVRA 481.7M
- IPO Year
- SD 2007
- ZVRA 2015
- Fundamental
- Price
- SD $10.99
- ZVRA $9.74
- Analyst Decision
- SD
- ZVRA Strong Buy
- Analyst Count
- SD 0
- ZVRA 9
- Target Price
- SD N/A
- ZVRA $22.75
- AVG Volume (30 Days)
- SD 401.5K
- ZVRA 683.8K
- Earning Date
- SD 08-06-2025
- ZVRA 08-12-2025
- Dividend Yield
- SD 4.00%
- ZVRA N/A
- EPS Growth
- SD 33.83
- ZVRA N/A
- EPS
- SD 1.74
- ZVRA N/A
- Revenue
- SD $137,611,000.00
- ZVRA $40,588,000.00
- Revenue This Year
- SD $37.50
- ZVRA $292.31
- Revenue Next Year
- SD $5.17
- ZVRA $78.65
- P/E Ratio
- SD $6.32
- ZVRA N/A
- Revenue Growth
- SD 1.35
- ZVRA 46.47
- 52 Week Low
- SD $8.81
- ZVRA $4.20
- 52 Week High
- SD $14.04
- ZVRA $10.03
- Technical
- Relative Strength Index (RSI)
- SD 51.28
- ZVRA 65.74
- Support Level
- SD $10.60
- ZVRA $8.58
- Resistance Level
- SD $11.19
- ZVRA $9.43
- Average True Range (ATR)
- SD 0.35
- ZVRA 0.37
- MACD
- SD -0.11
- ZVRA -0.00
- Stochastic Oscillator
- SD 19.12
- ZVRA 80.00
About SD SandRidge Energy Inc.
SandRidge Energy Inc is a United States-based oil and natural gas company. It is engaged in the exploration, development, and production of crude oil, natural gas, and Natural gas liquids. Business activities of the group include Exploration and Production, Drilling and Oil Field Services, and Midstream Gas Services. Its primary areas of operation are the Mid-Continent in Oklahoma and Kansas.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.